androstenedione has been researched along with Adrenoleukodystrophy in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Assies, J; Haverkort, EB; Lieverse, R; Vreken, P | 1 |
| Grigull, A; Köhler, W; Sokolowski, P; Stoffel-Wagner, B; Wichers-Rother, M | 1 |
1 trial(s) available for androstenedione and Adrenoleukodystrophy
| Article | Year |
|---|---|
Effect of dehydroepiandrosterone supplementation on fatty acid and hormone levels in patients with X-linked adrenoleucodystrophy.
Topics: Adjuvants, Immunologic; Administration, Oral; Adrenoleukodystrophy; Adult; Androstenedione; Child; Dehydroepiandrosterone; Double-Blind Method; Erythrocytes; Fatty Acids; Fatty Acids, Unsaturated; Humans; Insulin-Like Growth Factor I; Male; Middle Aged | 2003 |
1 other study(ies) available for androstenedione and Adrenoleukodystrophy
| Article | Year |
|---|---|
Adrenal steroids in adrenomyeloneuropathy. Dehydroepiandrosterone sulfate, androstenedione and 17alpha-hydroxyprogesterone.
Topics: 17-alpha-Hydroxyprogesterone; Adrenoleukodystrophy; Adult; Aged; Androstenedione; Anti-Inflammatory Agents; Dehydroepiandrosterone Sulfate; Fluorescence Polarization Immunoassay; Hormone Replacement Therapy; Humans; Hydrocortisone; Male; Middle Aged; Statistics, Nonparametric | 2005 |